RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Weigao Group Medical Polymer Co Stock

Shandong Weigao Group Medical Polymer Co Debt 2024

Shandong Weigao Group Medical Polymer Co Debt

-2,819.41 CNY

Ticker

1066.HK

ISIN

CNE100000171

WKN

A0M4WA

In 2024, Shandong Weigao Group Medical Polymer Co's total debt was -2,819.41 CNY, a -69.8% change from the -9,335.37 CNY total debt recorded in the previous year.

Shandong Weigao Group Medical Polymer Co Aktienanalyse

What does Shandong Weigao Group Medical Polymer Co do?

Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004. The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide. The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients. Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin. The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries. The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards. In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries. In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Shandong Weigao Group Medical Polymer Co's Debt Structure

Shandong Weigao Group Medical Polymer Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Shandong Weigao Group Medical Polymer Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Shandong Weigao Group Medical Polymer Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Shandong Weigao Group Medical Polymer Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Shandong Weigao Group Medical Polymer Co stock

What is the debt of Shandong Weigao Group Medical Polymer Co this year?

Shandong Weigao Group Medical Polymer Co has a debt level of -2,819.41 CNY this year.

What was the debt of Shandong Weigao Group Medical Polymer Co compared to the previous year?

The debt of Shandong Weigao Group Medical Polymer Co has increased by -69.8% compared to the previous year dropped.

What are the consequences of high debt for investors in Shandong Weigao Group Medical Polymer Co?

High debt can pose a risk for investors of Shandong Weigao Group Medical Polymer Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Shandong Weigao Group Medical Polymer Co?

Low debt means that Shandong Weigao Group Medical Polymer Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Shandong Weigao Group Medical Polymer Co affect the company?

An increase in debt of Shandong Weigao Group Medical Polymer Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Shandong Weigao Group Medical Polymer Co affect the company?

A reduction in debt of Shandong Weigao Group Medical Polymer Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Shandong Weigao Group Medical Polymer Co?

Some factors that can influence the debt of Shandong Weigao Group Medical Polymer Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Shandong Weigao Group Medical Polymer Co so important for investors?

The debts of Shandong Weigao Group Medical Polymer Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Shandong Weigao Group Medical Polymer Co take to change the debt?

To change the debt, Shandong Weigao Group Medical Polymer Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Shandong Weigao Group Medical Polymer Co pay?

Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 5.29 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.

What is the dividend yield of Shandong Weigao Group Medical Polymer Co?

The current dividend yield of Shandong Weigao Group Medical Polymer Co is 5.29 %.

When does Shandong Weigao Group Medical Polymer Co pay dividends?

Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of July, July, November, November.

How secure is the dividend of Shandong Weigao Group Medical Polymer Co?

Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.

What is the dividend of Shandong Weigao Group Medical Polymer Co?

For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 5.76 %.

In which sector is Shandong Weigao Group Medical Polymer Co located?

Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Weigao Group Medical Polymer Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.01 CNY, you needed to have the stock in your portfolio before the ex-date on 10/22/2024.

When did Shandong Weigao Group Medical Polymer Co pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Shandong Weigao Group Medical Polymer Co in the year 2023?

In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.

In which currency does Shandong Weigao Group Medical Polymer Co pay out the dividend?

The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Weigao Group Medical Polymer Co

Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.